4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lipocine Inc. (LPCN) operates in the Biotechnology industry and is headquartered in Salt Lake City, United States with about 14 employees. Its market capitalization is roughly $18 million. In the fiscal year ended 2025-12-31, LPCN reported $2M in revenue and ($10M) in net income.
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.
Interactive charts & full statements → Open the LPCN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $11M | ($3M) | $0M | — |
| Gross Profit | ($7M) | $4M | ($13M) | ($8M) | — |
| Operating Income (EBIT) | ($10M) | ($1M) | ($18M) | ($12M) | — |
| Net Income | ($10M) | $0M | ($16M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $0M | $1M | $0M | — |
| Gross Profit | — | — | — | ($2M) | — | — |
| Operating Income (EBIT) | ($4M) | ($2M) | ($3M) | ($2M) | ($2M) | — |
| Net Income | ($4M) | ($2M) | ($3M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $17M | $22M | $23M | $38M | — |
| Total Liabilities | $2M | $2M | $3M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LPCN viewer.
About TickerBase · Data methodology & sources